|
Managing
Diabetes with Insulin, Insulin Analogs, and Premixed Insulin
Analogs
A
Continuing Education Program for Pharmacists, Nurses, and Dietitians
Please
read the following information and select the appropriate link
at the bottom of the page to continue.
Target
Audience: This continuing education (CE) program
is intended for pharmacists, nurses, and dietitians who work
with or anticipate working with patients with diabetes requiring
insulin.
Goal:
To provide information on the treatment of diabetes
with insulin, insulin analogs, and premixed insulin analogs.
Educational
Objectives: Upon completion of this activity, the
participant should be able to:
- State
the annual economic costs associated with diabetes
- Describe
the ADA criteria for diagnosis of diabetes
- Explain
the rationale for analog development
- Describe
3 different insulin regimens
- Describe
the practical aspects of insulin use
- Identify
2 possible causes of hypoglycemia
Initial
Release Date: 12/02/2003
Planned Expiration Date: 12/02/2005
To
receive a statement of credit, you must:
- Successfully
complete the post-test (70% or better).
- Complete
the program evaluation.
Your statement
of credit will be issued immediately upon successful completion
of the test and submission of the evaluation form. The statement
of credit specific to your discipline will appear on your screen
and you will be given the option to print it for your files.
No additional statement of credit will be issued.
Activity
Presenter:
Linda
Haas, CDE, RN, PhC, MN
Endocrinology Clinical Nurse Specialist
VA Puget Sound Health Care System
Clinical Assistant Professor of Nursing
University of Washington School of Nursing
Seattle, Washington
This
program is a presentation by Linda Haas. Ms. Haas is the Endocrinology
Clinical Nurse Specialist at the VA Puget Sound Health Care
System, Seattle Division and a Clinical Assistant Professor
of Nursing at the University of Washington School of Nursing.
Ms. Haas follows a caseload of patients with diabetes in the
Endocrine Clinic and participates in four nurse-run clinics
for the education and management of veterans with diabetes.
Ms.
Haas is a past president of the American Association of Diabetes
Educators (AADE) and past President, Health Care and Education
of the American Diabetes Association (ADA). She received AADE's
Distinguished Service Award in 1994, and ADA's Outstanding Educator
of the Year Award in 1995. In 1999, she received the Veteran's
Health Administration's National Award for Excellence in Nursing
(Expanded Role). Ms. Haas has lectured throughout the country
on diabetes management including medication management.
Fee:
There is no fee to receive credits for this continuing education
activity.
Commercial
Supporter: This program is supported by an educational
grant from Novo Nordisk Inc.
Trademarks:
NovoLog,
NovoPen, Novolin, Ultralente, Lente, PenFill, FlexPen, InnoLet,
and Innovo are registered trademarks of Novo Nordisk A/S.
InDuo is a registered trademark of LifeScan, Inc.
Humalog and Humulin are registered trademarks of Eli Lilly and
Company.
Lantus is a registered trademark of Aventis Pharmaceuticals,
Inc.
BD Pen is a trademark of Becton Dickinson and Company.
Mix75/25 is a trademark of Eli Lilly and Company.
Disclosure
Declaration:
It is the
policy of the American Association of Diabetes Educators and
Scherer Clinical Communications to ensure independence, balance,
objectivity, scientific rigor, and integrity in all of their
continuing education activities. The faculty must disclose to
the particpants any significant relationships with the commercial
companies whose products or devices may be mentioned in the
activity or with the supporter of this continuing education
activity. The information is for participant information; it
is not assumed that these relationships will have a negative
impact on the content of the activity.
Ms. Haas
has disclosed that she has received an honorarium for narrating
this activity.
Disclaimers:
- Approval of credit for this continuing education program
does not imply endorsement by AADE of any product or manufacturer
identified.
- Any medications or treatment methods suggested in this CE
activity should not be used by the practitioner without evaluation
of their patient's condition(s) and possible contraindication(s)
or danger(s) of use of any specific medication.
- This activity may include discussions of products or devices
that are not currently approved for use by the Food and Drug
Administration (FDA).
- The American
Association of Diabetes Educators, Scherer Clinical Communications,
the commercial supporter, and the activity's faculty do not
endorse the use of any product in a manner that is not approved
by the FDA.
The author,
sponsor, and publisher of this continuing education program
have made all reasonable efforts to ensure that information
contained herein is accurate in accordance with the latest available
scientific knowledge at the time of accreditation of this continuing
education program. Information regarding drugs (e.g., their
administration, dosages, contraindications, adverse reactions,
interactions, special warnings, precautions) and drug delivery
systems is subject to change, however, and the reader is advised
to check the manufacturer's package insert for information concerning
recommended dosage and potential problems or cautions prior
to dispensing or administering the drug or using the drug delivery
systems.
Click
the appropriate profession to continue to the activity:
Pharmacists
click here
Nurses
click here
Dietitians
click here
Other
Healthcare Professionals click here
Copyright©
2003 Scherer Clinical Communications. All rights reserved.
|
